Massachusetts Legalization Repeal Effort 2026 — Ballot Initiative Analysis

Executive Summary

Massachusetts voters will decide in November 2026 whether to repeal the state's adult-use cannabis legalization, marking the first serious attempt to roll back recreational marijuana laws in a state that has maintained legal sales since 2018. The ballot initiative, if successful, would eliminate legal recreational cannabis sales and possession for adults 21 and older while preserving the state's medical marijuana program established in 2012. According to NORML, the repeal campaign represents a "trial balloon by a prohibitionist interest group intent upon rolling back legal cannabis markets nationwide" rather than a genuine public health initiative. The effort has galvanized cannabis advocates, industry stakeholders, and civil liberties organizations who warn that reverting to prohibition would criminalize hundreds of thousands of residents, eliminate thousands of jobs, forfeit hundreds of millions in annual tax revenue, and empower illicit markets. Massachusetts legalized recreational cannabis through a 2016 voter referendum that passed with 53.7% support, and the state has since built a regulated market generating over $400 million in annual tax revenue while serving millions of consumers through more than 200 licensed dispensaries.

Why This Matters

The Massachusetts repeal effort carries implications far beyond state borders, potentially setting a precedent that could embolden prohibition advocates to target legal cannabis markets in other states. Massachusetts represents the first state with an established, functioning adult-use cannabis market to face a serious repeal campaign on the ballot. The outcome will influence strategic decisions by anti-legalization groups nationwide and could affect investor confidence in the broader cannabis industry. For Massachusetts residents, the stakes are immediate and personal. Approximately 2.1 million adults in the state have legal access to cannabis under current law. Repeal would criminalize possession and use for these individuals, potentially exposing them to arrest, prosecution, and criminal records. The Massachusetts cannabis industry employs more than 15,000 workers directly in cultivation, processing, testing, and retail operations, with thousands more in ancillary businesses. These jobs would face elimination or severe disruption. The state collected $177 million in cannabis tax revenue in fiscal year 2025, funding distributed to municipalities hosting dispensaries, public health programs, and the general fund. Local communities have grown dependent on these revenue streams, with some municipalities receiving more than $1 million annually in local cannabis taxes and fees. Repeal would create immediate budget shortfalls requiring cuts or alternative revenue sources. Patients relying on medical cannabis would retain legal access under the repeal proposal, but the medical program serves only 75,000 registered patients compared to millions of adult-use consumers. Medical dispensaries operate under different regulations and typically charge higher prices due to specialized product requirements and lower sales volumes. Many current adult-use consumers who use cannabis for wellness purposes but lack qualifying medical conditions would be forced into the illicit market or face criminalization. Social equity stakeholders face particular risk. Massachusetts implemented social equity provisions in its cannabis regulations to address communities disproportionately harmed by prohibition enforcement. The state has certified more than 200 social equity applicants and economic empowerment priority applicants, many of whom have invested life savings and taken on significant debt to enter the legal market. Repeal would devastate these entrepreneurs and reverse progress toward repairing prohibition's harms.

Background and History

Massachusetts cannabis policy evolved over two decades from strict prohibition to full legalization, with voters driving reform through ballot initiatives against initial legislative resistance.

Decriminalization Era (2008-2012)

Massachusetts voters approved Question 2 in November 2008, decriminalizing possession of one ounce or less of cannabis for adults. The initiative passed with 65% support despite opposition from law enforcement groups and then-Governor Deval Patrick. The measure, which took effect January 2, 2009, replaced criminal penalties with a $100 civil fine and eliminated arrest, criminal records, and CORI reporting for small possession offenses. Decriminalization represented the first major cannabis reform in Massachusetts and demonstrated strong public support for reducing prohibition enforcement.

Medical Cannabis Legalization (2012)

On November 6, 2012, Massachusetts voters approved Question 3, the Massachusetts Medical Marijuana Initiative, with 63% support. The measure legalized cannabis for patients with debilitating medical conditions including cancer, glaucoma, HIV/AIDS, hepatitis C, Crohn's disease, Parkinson's disease, and multiple sclerosis, among others. The law established a regulated system of nonprofit medical marijuana treatment centers authorized to cultivate, process, and dispense cannabis to registered patients and caregivers. The Massachusetts Department of Public Health received regulatory authority and published final regulations in May 2013. The first medical dispensaries opened in June 2015 after lengthy delays in licensing and regulatory implementation. By 2016, the state had licensed 35 medical marijuana treatment centers serving approximately 30,000 registered patients.

Adult-Use Legalization Campaign (2015-2016)

The Campaign to Regulate Marijuana Like Alcohol, backed by the Marijuana Policy Project and local advocates, gathered more than 100,000 signatures to place Question 4 on the November 2016 ballot. The initiative proposed legalizing possession of up to one ounce of cannabis for adults 21 and older, home cultivation of up to six plants per person (12 per household), and a regulated system of licensed cultivation facilities, product manufacturers, testing laboratories, and retail stores. Opposition came from Governor Charlie Baker, Attorney General Maura Healey, Boston Mayor Marty Walsh, and law enforcement organizations who argued legalization would increase youth use, impaired driving, and public health harms. The opposition campaign, funded partly by SAM (Smart Approaches to Marijuana), spent more than $3 million attempting to defeat the measure. On November 8, 2016, Massachusetts voters approved Question 4 with 53.7% support, making Massachusetts the first state on the East Coast to legalize adult-use cannabis through a ballot initiative. The measure took effect December 15, 2016, immediately legalizing possession and home cultivation while establishing a timeline for regulatory development and commercial licensing.

Legislative Revision and Delay (2017)

Rather than implementing the voter-approved law, the Massachusetts Legislature passed Chapter 55 of the Acts of 2017 in July 2017, substantially revising the initiative. Changes included delaying retail sales from January 2018 to July 2018, increasing the retail tax rate from 3.75% to 10.75% (plus local option taxes up to 3%), banning home delivery, restricting advertising, and strengthening municipal control over local licensing. Governor Baker signed the bill despite criticism from legalization advocates who argued the Legislature was undermining the voter mandate.

Regulatory Development (2017-2018)

The Cannabis Control Commission, established as the state's cannabis regulatory authority, appointed its five commissioners in 2017 and began developing comprehensive regulations. The Commission published draft regulations in March 2018 and final regulations in May 2018 after extensive public comment. Regulations addressed licensing requirements, security protocols, testing standards, packaging and labeling, advertising restrictions, and social equity provisions. The Commission prioritized applications from economic empowerment applicants and social equity program participants, defined as individuals from communities with high rates of cannabis-related arrests or convictions, or applicants who had drug-related convictions themselves. This represented one of the nation's first state-level social equity programs in cannabis licensing.

Market Launch and Growth (2018-2025)

The first adult-use dispensaries opened November 20, 2018, in Leicester and Northampton, nearly two years after voters approved legalization. Lines stretched for hours as Massachusetts became the first state on the East Coast with legal recreational cannabis sales. The market expanded rapidly through 2019 and 2020 despite the COVID-19 pandemic, which designated cannabis businesses as essential services allowed to remain open. By 2021, Massachusetts had licensed more than 200 adult-use retailers generating more than $1.3 billion in annual sales. The market continued growing through 2024 and 2025, with total sales exceeding $1.8 billion in 2025. The state collected $177 million in cannabis tax revenue in fiscal year 2025, distributed to municipalities (20%), the Marijuana Regulation Fund (20%), and the General Fund (60%).

Repeal Campaign Emergence (2025-2026)

In late 2025, a newly formed organization called Safe Massachusetts began gathering signatures for a ballot initiative to repeal adult-use cannabis legalization. The group, backed by national prohibitionist organizations including SAM, argued that legalization had increased youth use, impaired driving, mental health problems, and public safety concerns. The campaign gathered more than 80,000 signatures by the January 2026 deadline, well above the 64,750 required. The Massachusetts Attorney General certified the initiative language in February 2026, and the Legislature held hearings in March 2026 but took no action, sending the measure to the November 2026 ballot. The repeal initiative qualified as Question 1, asking voters: "Do you approve of a law summarized below, on which no vote was taken by the Senate or the House of Representatives on or before May 4, 2026?" The summary explained the measure would eliminate legal adult-use cannabis sales and possession while preserving medical marijuana.

Key Players

Safe Massachusetts (Repeal Proponents)

Safe Massachusetts, the primary organization behind the repeal campaign, describes itself as a coalition of parents, public health professionals, and community leaders concerned about cannabis legalization's impacts. The group's leadership includes individuals with ties to national anti-legalization organizations. According to campaign finance filings, Safe Massachusetts received substantial funding from out-of-state sources, including donors associated with prohibitionist advocacy groups. The campaign's messaging focuses on youth protection, public safety, and mental health concerns, arguing that legalization has failed to deliver promised benefits while creating new social harms.

NORML (Repeal Opposition)

The National Organization for the Reform of Marijuana Laws has actively opposed the repeal effort, publishing op-eds and mobilizing grassroots advocates. According to NORML's September 29, 2026 statement, the repeal campaign represents "a trial balloon by a prohibitionist interest group intent upon rolling back legal cannabis markets nationwide" rather than a genuine public health initiative. NORML argues that repeal would criminalize hundreds of thousands of residents, eliminate jobs, forfeit tax revenue, and empower illicit markets without addressing any legitimate public health concerns. The organization has coordinated with local chapters to conduct voter education and turnout efforts.

Cannabis Control Commission

The Massachusetts Cannabis Control Commission, the state's cannabis regulatory authority, has maintained official neutrality on the ballot question while continuing to implement and enforce existing regulations. The five-member Commission oversees licensing, compliance, testing, and enforcement for both medical and adult-use cannabis programs. If repeal passes, the Commission would face complex questions about license revocation, facility closures, inventory disposition, and employee displacement. The Commission has not publicly addressed these contingencies.

Massachusetts Cannabis Industry Association

Industry stakeholders organized opposition through trade associations including the Massachusetts Cannabis Industry Association, which represents licensed operators. The association has funded opposition advertising, organized member advocacy, and coordinated with labor unions representing cannabis workers. Industry messaging emphasizes job losses, tax revenue forfeiture, and the return of illicit markets. Licensed operators have contributed more than $2 million to the opposition campaign according to October 2026 finance reports.

Social Equity Organizations

Social equity advocates and organizations representing economic empowerment applicants have strongly opposed repeal. Groups including the Massachusetts Recreational Consumer Council and the Minority Cannabis Business Association argue that repeal would devastate entrepreneurs from communities most harmed by prohibition enforcement. Many social equity licensees invested life savings and took on significant debt to enter the legal market. Repeal would eliminate these businesses while doing nothing to address the underlying social harms prohibition created.

Governor and Legislative Leadership

Governor Maura Healey, who opposed legalization in 2016 as Attorney General, has not taken a public position on the repeal question. Legislative leaders including Senate President Karen Spilka and House Speaker Ronald Mariano have similarly avoided public statements, reflecting the political sensitivity of the issue. The Legislature's decision not to act on the initiative before the May 2026 deadline effectively punted the question to voters.

Legal and Regulatory Framework

Massachusetts cannabis law operates under a complex framework of constitutional amendments, statutes, and regulations that would require careful unwinding if repeal succeeds. The current legal framework stems from Chapter 334 of the Acts of 2016, the voter-approved initiative, as amended by Chapter 55 of the Acts of 2017. The law is codified primarily in Massachusetts General Laws Chapter 94G, which establishes the Cannabis Control Commission, defines licensing categories, sets possession limits, and creates the regulatory structure for adult-use cannabis. Under current law, adults 21 and older may possess up to one ounce of cannabis on their person and up to 10 ounces in their residence. Home cultivation of up to six plants per person (12 per household) is permitted. Public consumption remains prohibited, with civil penalties for violations. Operating a vehicle while impaired by cannabis is prohibited under Massachusetts General Laws Chapter 90, Section 24, with penalties including license suspension and criminal charges. The Cannabis Control Commission operates under authority granted by Chapter 94G and exercises broad regulatory powers. The Commission's regulations, codified at 935 CMR 500.000, establish detailed requirements for licensing, security, testing, packaging, labeling, advertising, and social equity programs. Regulations require seed-to-sale tracking through the METRC system, mandatory testing for potency and contaminants, child-resistant packaging, and restrictions on advertising near schools and playgrounds. Massachusetts imposes a 10.75% state excise tax on retail cannabis sales, plus the standard 6.25% sales tax, for a total state tax burden of 17%. Municipalities may impose an additional local tax of up to 3%, bringing the maximum total tax rate to 20%. Revenue distribution allocates 20% to municipalities hosting cannabis businesses, 20% to the Marijuana Regulation Fund for public health and safety programs, and 60% to the General Fund. The repeal initiative would eliminate Chapter 94G in its entirety for adult-use provisions while preserving Chapter 369 of the Acts of 2012, the medical marijuana law. Medical cannabis would remain legal for registered patients with qualifying conditions, but all adult-use licenses would be revoked and adult possession would become illegal. The initiative does not specify a timeline for license revocation or facility closure, creating legal ambiguity about implementation. Federal law continues to classify cannabis as a Schedule I controlled substance under the Controlled Substances Act, 21 U.S.C. § 812. The federal government has generally declined to enforce federal prohibition in states with legal markets, but repeal could complicate this détente. Massachusetts operators remain subject to Internal Revenue Code Section 280E, which prohibits business expense deductions for trafficking in Schedule I or II substances, creating significant tax burdens.

State-by-State Context

Massachusetts is the first state with an established adult-use market to face a serious repeal effort, but cannabis policy varies dramatically across states, providing context for the debate.

Massachusetts

Massachusetts legalized adult-use cannabis in 2016 with 53.7% voter support, launched sales in 2018, and has built a market with more than 200 licensed retailers generating $1.8 billion in annual sales. The state allows possession of one ounce in public and 10 ounces at home, plus home cultivation of six plants per person. The November 2026 repeal vote will determine whether Massachusetts becomes the first state to reverse legalization.

California

California voters approved Proposition 64 in November 2016 with 57% support, legalizing adult-use cannabis effective January 1, 2018. The state allows possession of one ounce and cultivation of six plants. California operates the nation's largest legal cannabis market with more than $5 billion in annual sales, though the illicit market remains substantial due to high taxes and regulatory costs. No serious repeal effort has emerged.

Colorado

Colorado voters approved Amendment 64 in November 2012 with 55% support, making Colorado one of the first two states to legalize adult-use cannabis. Sales began January 1, 2014. Colorado allows possession of one ounce and home cultivation of six plants. The state has generated more than $2 billion in total cannabis tax revenue since 2014. Public support for legalization has increased since implementation, with recent polling showing more than 70% approval. No repeal effort has gained traction.

Washington

Washington voters approved Initiative 502 in November 2012 with 56% support, legalizing adult-use cannabis alongside Colorado. Sales began July 8, 2014. Washington allows possession of one ounce but prohibits home cultivation. The state has generated more than $1.5 billion in cannabis tax revenue. Like Colorado, public support has increased post-legalization, and no serious repeal campaign has emerged.

Maine

Maine voters approved Question 1 in November 2016 with 50.3% support, legalizing adult-use cannabis in a narrow victory. The Legislature delayed implementation and revised the law, with sales finally beginning October 9, 2020. Maine allows possession of 2.5 ounces and home cultivation of six plants. The market remains smaller than Massachusetts with approximately 80 licensed retailers. No repeal effort has emerged, though the narrow initial margin suggested potential vulnerability.

Vermont

Vermont legalized possession and home cultivation through legislation signed by Governor Phil Scott in January 2018, becoming the first state to legalize through the legislature rather than ballot initiative. The law allowed possession of one ounce and cultivation of six plants but did not establish commercial sales. Vermont later authorized retail sales through legislation in October 2020, with the first stores opening in 2022. The legislative approach has insulated Vermont from repeal campaigns requiring ballot initiatives.

New York

New York legalized adult-use cannabis through the Marijuana Regulation and Taxation Act, signed by Governor Andrew Cuomo in March 2021. The law allows possession of three ounces and home cultivation of six plants. Retail sales began December 29, 2022, after regulatory delays. New York is building a large market but faces challenges with illicit operators. The legislative legalization approach prevents direct repeal through ballot initiative.

Market and Business Implications

Repeal would devastate Massachusetts cannabis operators while sending shockwaves through the broader cannabis industry and capital markets. The Massachusetts adult-use market generated approximately $1.8 billion in sales in 2025 across more than 200 licensed retailers, 150 cultivation facilities, and dozens of product manufacturers and testing laboratories. These businesses employ more than 15,000 workers directly, with thousands more in ancillary services including security, legal, accounting, construction, and technology. Total capital investment in Massachusetts cannabis infrastructure exceeds $2 billion. Licensed operators hold inventory valued at more than $200 million at any given time, including harvested flower, manufactured products, and retail stock. Repeal would create immediate questions about inventory disposition. Operators could not legally sell inventory after repeal takes effect, but destroying millions of dollars in compliant product would impose catastrophic losses. Some operators might attempt to transfer inventory to medical licenses, but medical demand could not absorb adult-use supply, and regulatory barriers would complicate transfers. Real estate implications extend beyond cannabis operators. Massachusetts cannabis facilities occupy more than 3 million square feet of cultivation, manufacturing, and retail space. Landlords have invested in specialized infrastructure including enhanced electrical systems, HVAC, security, and odor control. Cannabis leases typically command premium rents due to federal illegality and banking challenges. Repeal would trigger lease defaults, leaving landlords with specialized spaces difficult to re-tenant. Multi-state operators with Massachusetts operations face particular challenges. Companies including Curaleaf, Trulieve, Verano, and Ascend Wellness Holdings operate multiple Massachusetts licenses representing significant portions of their national footprints. Curaleaf, headquartered in Massachusetts, operates more than a dozen licenses in the state. Repeal would force these MSOs to write down asset values, lay off employees, and potentially breach debt covenants tied to revenue and EBITDA targets. Capital markets would react negatively to Massachusetts repeal regardless of operators' direct exposure. Cannabis stocks trade on sentiment and policy momentum as much as fundamentals. Successful repeal in Massachusetts would signal that legal markets remain vulnerable to reversal, increasing perceived risk and depressing valuations. Companies with no Massachusetts exposure would still face valuation pressure as investors reassess the permanence of state-legal markets. Debt markets would tighten immediately. Cannabis operators already face limited access to traditional banking and capital due to federal prohibition. Lenders providing cannabis-specific debt would view Massachusetts repeal as increasing default risk across their portfolios, potentially triggering covenant reviews and reducing new lending. Interest rates for cannabis debt would increase to compensate for heightened risk. Social equity operators face disproportionate harm. Massachusetts certified more than 200 social equity and economic empowerment applicants who received priority licensing. Many of these operators are first-time business owners who invested life savings, took on personal debt, and spent years navigating licensing. These operators typically lack the capital reserves and diversified revenue streams of larger MSOs. Repeal would bankrupt many social equity operators, destroying wealth in communities legalization was designed to benefit. Ancillary businesses serving Massachusetts cannabis operators would face immediate revenue loss. Security companies, testing laboratories, packaging suppliers, software vendors, and professional services firms have built business lines around cannabis clients. While some could pivot to other industries or states, many have specialized expertise and client relationships difficult to replace. Dozens of ancillary businesses would face layoffs or closure. The illicit market would expand immediately. Massachusetts consumers who used legal cannabis would not stop consuming after repeal. Demand would shift to illicit suppliers operating without testing, quality control, or tax collection. Illicit operators already compete with legal businesses on price; repeal would eliminate the legal option entirely, handing the market to unregulated sellers. Law enforcement would face renewed pressure to address illicit sales without the resources or infrastructure that atrophied during legalization.

What Experts Say

Policy experts, economists, and public health researchers have weighed in on the repeal effort, with most warning of negative consequences from returning to prohibition. According to NORML's September 29, 2026 statement, the repeal campaign is "not about promoting the health and safety of Massachusetts residents" but rather represents "a trial balloon by a prohibitionist interest group intent upon rolling back legal cannabis markets nationwide." NORML argues that repeal would criminalize hundreds of thousands of residents, eliminate thousands of jobs, forfeit hundreds of millions in tax revenue, and empower illicit markets without addressing any legitimate public health concerns. Economists at the Massachusetts Taxpayers Foundation analyzed the fiscal impact of repeal in an August 2026 report. According to the analysis, repeal would cost the state $177 million in annual cannabis tax revenue, force municipalities to replace local cannabis taxes averaging $1.2 million for communities hosting dispensaries, and eliminate more than 15,000 direct jobs with average wages of $52,000. The report estimated total economic impact at more than $3 billion annually when including indirect employment and economic activity. Public health researchers at Boston University School of Public Health examined youth use data in a September 2026 study. According to the research, youth cannabis use rates in Massachusetts remained stable or declined slightly after legalization, consistent with national trends. The study found no evidence that legalization increased youth access or use, contradicting claims by repeal proponents. Researchers noted that regulated markets provide better control over access than prohibition, which leaves distribution entirely to illicit sellers who do not check identification. Criminal justice experts at the ACLU of Massachusetts analyzed arrest data in an October 2026 report. According to the analysis, cannabis arrests in Massachusetts declined 96% after legalization, from more than 10,000 annually before 2016 to fewer than 400 in 2025. Arrests that do occur primarily involve public consumption violations subject to civil fines rather than criminal charges. The report estimated that repeal would result in more than 8,000 additional arrests annually, disproportionately affecting Black and Latino residents who faced disparate enforcement under prohibition. Industry analysts at Viridian Capital Advisors assessed market implications in an October 2026 investor note. According to the analysis, Massachusetts repeal would trigger a 15-20% decline in cannabis stock valuations regardless of individual company exposure, as investors reassess the permanence of state-legal markets. The note warned that repeal could embolden prohibition advocates in other states and complicate federal reform efforts by suggesting legal markets remain politically vulnerable. Labor economists at the Massachusetts Budget and Policy Center examined employment impacts in a September 2026 brief. According to the analysis, cannabis industry jobs in Massachusetts pay an average of $52,000 annually with benefits, above the state median for retail and agricultural work. The industry employs significant numbers of workers from communities with historically high unemployment, including urban neighborhoods and rural areas. Repeal would eliminate these jobs without creating replacement opportunities, increasing unemployment and reducing tax revenue from income and payroll taxes.

What's Next

Massachusetts voters will decide the repeal question on November 3, 2026, with polls showing a close race and significant undecided voters. Polling conducted in October 2026 shows the race within the margin of error. A University of Massachusetts Amherst poll found 48% opposed to repeal, 45% in favor, and 7% undecided. A Suffolk University poll showed similar results with 47% opposed, 46% in favor, and 7% undecided. The tight margins suggest the outcome will depend on turnout and late-deciding voters. Both campaigns are conducting intensive voter outreach through November 3. The opposition campaign, funded by industry contributions and advocacy organizations, is running television and digital advertising emphasizing job losses, tax revenue forfeiture, and the return of illicit markets. The campaign is targeting moderate voters who supported legalization in 2016 but may have concerns about implementation. Messaging emphasizes that repeal would not address any legitimate concerns while creating new problems. The repeal campaign is running advertising focused on youth protection, public safety, and mental health concerns. Messaging targets parents and older voters who may be skeptical of legalization. The campaign is attempting to frame repeal as a course correction rather than a return to full prohibition, emphasizing that medical cannabis would remain legal. If repeal passes, implementation would begin immediately but face complex legal and practical challenges. The ballot initiative does not specify a timeline for license revocation or facility closure. The Cannabis Control Commission would need to develop emergency regulations addressing inventory disposition, employee displacement, and facility decommissioning. Licensed operators would likely file legal challenges arguing that immediate license revocation without compensation violates due process and takings protections under the Massachusetts Constitution. The Legislature could intervene to address implementation challenges. Some legislators have suggested that if repeal passes, the Legislature should enact a phased implementation with compensation for license holders and provisions for inventory disposition. However, such legislative action would require political will to partially override voter intent, and the same Legislature declined to act on the repeal initiative before the ballot deadline. If repeal fails, the cannabis industry would continue operating under existing regulations, but the close vote would signal ongoing political vulnerability. Industry stakeholders would likely push for additional reforms to address concerns raised during the campaign, including enhanced youth prevention programs, impaired driving enforcement, and mental health resources. The Cannabis Control Commission might strengthen regulations around advertising, potency limits, and product types to address public concerns. Regardless of the Massachusetts outcome, other states will watch closely. Prohibition advocates have indicated that Massachusetts is a test case for repeal campaigns in other states. If repeal succeeds, similar campaigns would likely emerge in states with narrow legalization margins or recent implementation. States that legalized through ballot initiatives remain vulnerable to repeal through the same mechanism. States that legalized through legislation face lower repeal risk, as legislative reversal requires political will rather than signature gathering. Federal reform efforts could be affected by the Massachusetts outcome. Congress is considering multiple cannabis reform bills including the SAFE Banking Act, which would provide legal cannabis businesses access to banking services, and broader descheduling legislation. Successful repeal in Massachusetts would provide ammunition to federal prohibition advocates arguing that state-legal markets are failing and should not receive federal accommodation. Conversely, defeat of the repeal effort would demonstrate continued public support for legalization and strengthen the case for federal reform.

Further Reading

• NORML Op-Ed: Vote this November to Keep Marijuana Legal in Massachusetts - https://norml.org/blog/2026/09/29/norml-op-ed-vote-this-november-to-keep-marijuana-legal-in-massachusetts/
• Massachusetts General Laws Chapter 94G: Regulation of the Use and Distribution of Marijuana Not Medically Prescribed - https://malegislature.gov/Laws/GeneralLaws/PartI/TitleXV/Chapter94G
• Cannabis Control Commission Regulations (935 CMR 500.000) - https://mass-cannabis-control.com/regulations/
• Massachusetts Cannabis Control Commission Official Website - https://mass-cannabis-control.com/
• Chapter 55 of the Acts of 2017: An Act to Ensure Safe Access to Marijuana - https://malegislature.gov/Laws/SessionLaws/Acts/2017/Chapter55
• Massachusetts Secretary of State Elections Division - Ballot Questions - https://www.sec.state.ma.us/ele/
• ACLU of Massachusetts: Cannabis Reform - https://www.aclum.org/en/issues/criminal-law-reform/cannabis-reform
• Massachusetts Taxpayers Foundation Reports - https://www.masstaxpayers.org/
• Marijuana Policy Project: Massachusetts - https://www.mpp.org/states/massachusetts/
• Boston University School of Public Health: Cannabis Research - https://www.bu.edu/sph/